Apex Financial Statements From 2010 to 2024
| 1733 Stock | TWD 28.50 0.15 0.53% |
Check Apex Biotechnology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Apex Biotechnology's main balance sheet or income statement drivers, such as , as well as many indicators such as . Apex financial statements analysis is a perfect complement when working with Apex Biotechnology Valuation or Volatility modules.
Apex |
Apex Biotechnology Corp Company Current Valuation Analysis
Apex Biotechnology's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Apex Biotechnology Current Valuation | 2.45 B |
Most of Apex Biotechnology's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Apex Biotechnology Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Apex Biotechnology Corp has a Current Valuation of 2.45 B. This is 82.97% lower than that of the Health Care Equipment & Supplies sector and 47.35% lower than that of the Health Care industry. The current valuation for all Taiwan stocks is 85.29% higher than that of the company.
Apex Biotechnology Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Apex Biotechnology's current stock value. Our valuation model uses many indicators to compare Apex Biotechnology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Apex Biotechnology competition to find correlations between indicators driving Apex Biotechnology's intrinsic value. More Info.Apex Biotechnology Corp is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.34 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Apex Biotechnology Corp is roughly 2.95 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Apex Biotechnology's earnings, one of the primary drivers of an investment's value.About Apex Biotechnology Financial Statements
Apex Biotechnology investors use historical fundamental indicators, such as Apex Biotechnology's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Apex Biotechnology. Please read more on our technical analysis and fundamental analysis pages.
Apex Biotechnology Corp. engages in the research, development, manufacture, and sale of medical devices by using biosensor technology worldwide. Apex Biotechnology Corp. was founded in 1997 and is headquartered in Hsinchu, Taiwan. APEX BIOTECHNOLOGY operates under Biotechnology classification in Taiwan and is traded on Taiwan Stock Exchange.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Apex Stock Analysis
When running Apex Biotechnology's price analysis, check to measure Apex Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apex Biotechnology is operating at the current time. Most of Apex Biotechnology's value examination focuses on studying past and present price action to predict the probability of Apex Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apex Biotechnology's price. Additionally, you may evaluate how the addition of Apex Biotechnology to your portfolios can decrease your overall portfolio volatility.